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Purpose: The aim of this study was to investigate the antitumor effect of the chloroform and ethanol 
extract of the whole plant of Cuscuta reflexa Roxb. (Cuscutaceae)  in Swiss albino mice against Ehrlich 
Ascites Carcinoma (EAC) cell line. 
Methods: The antitumor activity of the chloroform and ethanol extracts of Cuscuta reflexa was 
evaluated against Ehrlich ascites carcinoma (EAC) tumor in mice at doses of 200 and 400 mg/kg body 
weight orally, respectively, while acute oral toxicity studies were performed to determine the safety of 
the extracts. Briefly, the EAC cells were injected (i.p.) into ninty six mice (divided into 6 numerically 
equal groups), and after a one-day incubation period, the extracts were administered to the mice daily 
for 16 days. On day 21, six animals in each group  were sacrificed for observation of antitumor activity 
and the remaining animals were observed to determine host the life span. Antitumor effect was 
determined by evaluating tumor volume, viable and nonviable tumor cell count and hematological 
parameters of the host. The standard antitumor used was 5-fluorouracil. 
Results: Administration of the extracts resulted in a significant (p < 0.05) decrease in tumor volume and 
viable cell count, but increased non-viable cell count and mean survival time, thereby increasing the life 
span of the tumor-bearing mice. Restoration of hematological parameters - red blood cells (RBC), 
hemoglobin, white blood cells (WBC) and lymphocyte count - to normal levels in extract-treated mice 
was also observed. 
Conclusion: The results suggest that the chloroform and ethanol extracts of C. reflexa exhibit 
significant antitumor activity in EAC-bearing mice that is comparable to that of the reference standard, 5-
fluorouracil. 
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INTRODUCTION 
 
Malignancy is one of the most serious 
diseases afflicting mankind today and indeed, 
the second most deadly disease after heart 
disease. According to WHO estimates, more 
than 7 million people died of cancer in 
2005[1]. There exists a close relationship 
between the occurrence, growth and decline 
of tumor. In recent times, the demand for 
more effective and safer therapeutic agents 
for the chemoprevention of human cancer 
has increased. Natural products produced by 
plants and their synthetic derivatives are 
expected to play an important role in the 
development of innovative agents to inhibit 
the onset of cancer [1]. There is a growing 
interest in the pharmacological evaluation of 
various plants used in the Indian traditional 
system of medicine.  
 
Cuscuta reflexa (Cuscutaceae), known in 
Hindi as Amarbela, is a phanerogamic stem 
parasite, and is distributed worldwide. The 
species are rootless, leafless twining annual 
parasites with yellowish stems, distributed 
across tropical and temperate regions, and in 
India about 6 species are found. It grows on 
thorny or other shrubs, sometimes completely 
covering bushes and trees [2]. C. reflexa 
spread from one host to another, and on 
each victim, they twine and cling tightly with 
special branching organs called houstoria, 
penetrating the host and connecting to the 
host xylem as well as to the host phloem, and 
absorbing from it both water and elaborated 
food stuffs such as sugars and amino acids 
[3]. Various parts of this plant are used in 
tribal medicine for the diseases such as 
impotence, premature ejaculation, sperm 
leakage, frequent urination, ringing in the 
ears, lower back pain, sore knees, 
leucorrhea, dry eyes, blurred vision, and tired 
eyes.  
 
Cuscuta is one of nine herbs included in the 
manufacture of Equiguard, a Chinese herbal 
medicine recommended for kidney and 
prostate disorders. Research performed at 
New York Medical College indicates that the 
combination of ingredients in Equiguard may 
well be effective in the treatment of prostate 
cancer. The preparation inhibited the growth 
of cancer cells, increased the rate of self-
destruction (apoptosis) of cancer cells, and 
prevented the surviving cells from forming 
colonies [4]. Phytochemical investigation of 
Cuscuta reflexa indicates the presence of 
kaempferol-3-O-glucoside, astragallin [5], 
myrecetin, benzopyrones [6], glucopyra-
nosides [7], propenamide, flavonols [8], 
quercetin and quercetin-3-O-glucoside, β-
sitosterol, and bergenin [9].  
 
The objective of the present study was to 
evaluate the antitumor effect of Cuscuta 
reflexa against Ehrlich’s Ascites Carcinoma 




Plant materials  
 
Whole plants were collected from PNT 
Square, Jawahar Chowk, Bhopal (M.P.) 
India, during the months of January and 
February 2007. The species was identified by 
the local people during the time of collection 
and later authenticated by Dr Pradeep Tiwari, 
taxonomist, Department of Botany, Dr. H.S. 
Gour University, Sagar (M.P.), India. A 
voucher specimen (no. BOT/412/123) was 
prepared and preserved along with the crude 
drug sample at the herbarium of Department 
of Botany, Dr. H.S. Gour University, Sagar 
(M.P.), India. The whole plant was shade-
dried, reduced to coarse powder and stored 
in an airtight container until further use. 
 
Preparation of extract 
 
The powdered drug (1 kg) was packed in a 
Soxhlet apparatus and extracted for 24 h  
with petroleum ether (60 - 80 ºC) to defat the 
drug. The defatted material was then 
extracted with chloroform (2.5 L). The 
chloroform extract was separated while the 
marc was extracted with ethanol (2.5 L, 95 
%). The solvent, in each case, was removed 
by evaporation and the residual solvent 
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eliminated under reduced pressure. Separate 
solutions of the chloroform and ethanol 
extracts were prepared in two doses - 200 
and 400 mg/kg - for the antitumor test. 
 
Experimental animals  
 
Swiss albino mice, weighing (23 – 25 g), 
were used in this study. They were 
maintained in a well-ventilated room at a 
temperature of 25 ± 1° C with 12/12 h 
light/dark cycle in polypropylene cages. 
Standard pellet feed and tap water were 
provided ad libitum throughout the 
experimentation period. The animals were 
acclimatized to laboratory conditions for 10 
days prior to initiation of experiments. The 
project proposal was approved by the 
Institutional Animal Ethical Committee (ref.  
no. IAEC/A/500/2001).  
 
Acute oral toxicity study  
 
Acute oral toxicity test was performed by 
following OECD guideline – 420 [10]. 
Increasing doses of the extracts, up to 2000 





Ehrlich ascites carcinoma (EAC) cells were 
obtained from the National Centre for Cell 
Science, Pune, India and maintained in vivo 
in Swiss albino mice, by intraperitoneal (i.p.) 
transplantation of 1×10
6
 cells/mouse every 10 
days. The mice were divided into six groups 
of 16 animals  each. EAC cells were collected 
from the donor mice and suspended in sterile 
isotonic saline (0.9 % NaCl). The viable EAC 
cells were counted (with the aid of trypan 
blue staining) under the microscope and were 
adjusted to 10
6
 cells/mL. An amount (0.1 mL) 
of these cells per 10 g body weight of the 
animals was injected (i.p.) into the animals on 
day 0. One day of incubation was allowed for 
multiplication of the cells.  
 
Ninety six animals were used for study and 
they were divided into six groups of 16 
animals each. Group I served as control mice 
and was administered 0.9 % NaCl solution for 
16 days. Group II EAC mice administered 
orally chloroform extract (200 mg/kg). Group 
III received orally chloroform extract (400 
mg/kg); Group IV ethanol extract (200 mg/kg, 
orally); Group V ethanol extract (400 mg/kg, 
orally); and Group VI the standard drug, 5-
fluorouracil (20 mg/kg, i.p.). The treatments 
continued daily for 16 days. On day 21, six 
animals from each group were sacrificed and 
the remaining animals were kept for further 
observation for 3? weeks to determine host 
life span.  
 
Determination of antitumor parameters  
 
Tumor volume: The mice were dissected and 
the ascitic fluid was collected from the 
peritoneal cavity. The fluid volume was 
measured in a graduated centrifuge tube and 
packed cell volume was determined after 
centrifuging (REMI, R4C and REMI Group) at 
1000 rpm for 5 min.  
Viable/non-viable tumor cell count: The cells 
from the preceding test were stained with 
trypan blue (0.4 % in normal saline) dye. The 
cells that took up the dye were non-viable 
while those that did not were viable. Viable 
and nonviable cells were counted and cell 
count computed as in Eq 1.  
 
   Cell count = C/(A x T) …………….. (1)   
 
where C is the number of cells (viable or 
nonviable) multiplied by the dilution factor, A 
is the area occupied by the liquid film and T is 
the thickness of the liquid film. 
 Increase in life span: The effect of extract on 
tumor growth was monitored by recording 
mice mortality daily for a period of 6 weeks 
from the starting day and the percent 
increase in life span (ILS) was calculated for 
each animal group with respect to the control 
[15-18].  
Hematological parameters: At the end of the 
experimental period, all the mice were 
sacrificed by cervical dislocation. Blood was 
collected from a freely flowing tail vein and 
used for the estimation hemoglobin (Hb) 
content, as well as for red blood cell (RBC) 
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and white blood cell (WBC) counts. WBC 
differential count was carried out using 
Leishman stained blood smears [11-17]. 
 
Statistical analysis  
 
The results of estimation of biochemical and 
functional parameters are reported as mean 
value ± standard error of mean (SEM). 
Variation within a set of data assessed by 
one-way analysis of variance (ANOVA) while 
individual comparison of group mean values 
by Dunnet’s test (Sigma Stat 3.5). P values < 






The extracts elicited tumor growth response 
with respect to packed cell volume, viable 
and non-viable cell counts and increase in life 
span. Table 1 indicates that the extracts, at 
doses of 200 and 400 mg/kg, respectively, as 
well as the reference standard drug, 5-
fluorouracil, reduced significantly (p < 0.05) 
tumor volume, when compared with the 
control group. A similar finding was made for 
viable cell count. The number of non-viable 
cell count significantly (p < 0.05) increased in 
ethanol extract-treated (at a dose of 400 
mg/kg) and reference standard groups, but 
no significant increase was observed in other 
extract-treated groups.  
 
As Table 3 shows, median survival time and 
life span of the mice increased following 
administration of the extracts at both doses 
(200 and 400 mg/kg), thus indicating that the 
extracts exhibited a remarkable capacity to 
inhibit the growth of solid tumor induced by 





The extracts of C. reflexa did not provoke any 
gross behavioral changes or manifestations  
of toxic symptoms in the animals, such as 
weight loss, increased motor activity, tremors, 
spasticity, loss of right reflex, decreased 
motor activity, ataxia, sedation,  muscle 
relaxation, hypnosis, arching and  rolling, 
lacrimation, salivation, watery diarrheoa, 
writhing and urination, over an observation  
period of 24 h. The  extracts were non-lethal 
even at the maximum single oral dose of 
2000 mg/kg.  
 
Table 1: Antitumor activity of Cuscuta reflexa 
extracts with regard to tumor volume, viable tumor 




















































































































































*P <0.05 compared to control group 
 
Hematological effects of the extracts 
 
Table 3 shows that after 16 days of 
treatment, the hematological parameters of 
the mice were significantly (p < 0.05) altered, 
compared to the control group. While total 
WBC count increased and Hb content of RBC 
decreased in the control group, RBC count 
and hemoglobin content increased in extract-
treated groups. Furthermore, there was 
decrease in WBC count, as well as counts of 
neutrophils and monocytes in extract- and 
reference standard-treated groups, while 
lymphocyte count rose for these groups.  
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Table 2: Antitumor activity of Cuscuta reflexa 
extracts with regard to median survival time and 
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The results of the present study indicate the 
tumor inhibitory activity of both the chloroform 
and ethanol extracts of Cuscuta reflexa 
against EAC cells.  Usually, the parameters 
for evaluating the antitumor activity of a drug 
are prolongation of life span, reduction in 
tumor volume and improvement in the 
hematological parameters of the host.  
Ascitic tumor implantation promotes local 
inflammatory reactions leading to increase in 
vascular permeability, and results in intense 
edema formation, cellular migration and 
progressive ascitic fluid formation. Ascitic 
fluid is essential to tumor growth, since it 
constitutes the direct nutritional source for 
tumor cells. Decrease in viable cell count and 
increase in non-viable cell count in tumor-
bearing mice suggest antitumor activity 
against EAC cells in mice [18, 19].  
Biological agents, such as interferons and 
interleukins, provide non-specific active 
immunity (indirect cytotoxic action), whereas 
monoclonal antibodies provide passive 
immunity (direct cytotoxic action). Interferons 
are the small proteins synthesized by the 
immune cells in response to various stimuli, 
such as viral infections and cytokines, and 
inhibit viral replication and promote cellular (T 
cell) immune response.  Interferons act via 
specific cellular receptors linked with JAK-
STAT (Janus Kinase-Signal Transducer 
and Activator of Transcription) pathway to 
stimulate the formation of specific proteins 
which mediate their actions. Their antitumor 
action is complex, and includes 
antiproliferative effects, promotion of 
differentiation, immunomodulation, alteration 
 
 
Table 3: Effect of Cuscuta reflexa extracts on hematological parameters of Swiss albino mice 
(mean ± SEM, n = 6) 
 
Differential count 









Control 12.1±0.3 1.29±0.01 17.5±0.28 20.1±3.2 65.2±7.3 4.2±0.5 
CHCl3 extract 
(200mg/kg) 
12.6±0.2 1.31±0.03 15.17±0.30* 39.5±4.2 53.7±6.2 3.9±0.2 
CHCl3 extract 
(400mg/kg) 
14.3±0.2* 1.35±0.02 11.2±0.35* 50.6±4.8 32.4±5.8* 3.1±0.4 
Ethanol extract 
(200mg/kg) 
13.5±0.2* 1.36±0.04 12.67±0.27* 43.2±5.1* 42.6±5.4* 3.4±0.5 
Ethanol extract 
(400mg/kg) 
15.9±0.3* 1.45±0.05* 7.03±0.24* 66.6±4.6* 24.5±3.8* 2.8±0.3* 
5-fluorouracil 
(20 mg/kg) 
16.1±0.1* 1.42±0.05* 7.31±0.26* 62.5±3.7* 26.7±7.6* 2.6±0.6* 
*P <0.05 compared to control group  
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in tumor cell surface antigen expression, 
inhibition of oncogene activation, and 
angiogenesis. The cytokines produced in the 
body by the lymphocytes are known as 
interleukins and they mediate cytotoxic 
actions through the cell surface receptors in 
relevant target cells. Interleukins stimulate 
the growth and activity of immune cells, 
which target cancer cells. It acts as an 
antitumor agent by increasing the cytolytic 
activity of antigen-specific cytotoxic T 
lymphocytes and natural killer (NK) cells and 
by increasing the gene expression 
responsible for encoding the lytic component 
of cytotoxic granules, that is, perforin and 
granzymes.  
 
Monoclonal antibodies are the clones of 
similar antibodies that are directed against 
specific target antigens.  Tumor cells express 
a wide variety of antigens that are attractive 
targets for monoclonal antibody-based 
therapy. These antibodies can activate the 
immune functions and facilitate the 
destruction of malignant cells by 




Reduction in viable cell count and increased 
non-viable cell count towards normal in tumor 
host suggested that extracts stimulate the 
growth and activity of immune cells by the 
production of Interleukins, which target tumor 
cells and cause lysis of the tumor cells by 
indirect cytotoxic mechanism. Furthermore, 
the reduced volume of EAC and increased 
survival time of the mice suggest that the 
extracts might have exerted a delay in 
vascular permeability to the cells [20]. While 
the standard drug, 5-fluorouracil as a 
pyrimidine analogue, is transformed inside 
the cell into different cytotoxic metabolites 
which are then incorporated into DNA and 
RNA, eventually inducing cell cycle arrest 
and apoptosis by inhibiting the cell's ability to 
synthesize DNA. The standard drug activity 
thus indicates a gene expression mechanism, 
which is indirect cytotoxicity The antitumor 
activity of the extracts appear to also follow 
this mechanism.      
 
Preliminary phytochemical screening 
indicated the presence of flavonoid, 
triterpenoids, alkaloids and tannins in the 
ethanol extract, and phytosterols, 
triterpenoids and alkaloids in the chloroform 
extract. It has been reported that flavonoids 
possess antimutagenic and antimalignant 
effects. Moreover, flavonoids have a 
chemopreventive role in cancer through their 
effects on signal transduction in cell 
proliferation and angiogenesis. The antitumor 
properties of the extracts may be due to 
these compounds. Phytosterols are able to 
be incorporated into the cell membrane, 
where they alter membrane fluidity and the 
activity of membrane-bound enzymes. They 
also alter signal transduction in pathways 
leading to tumor growth and stimulate 
apoptosis in tumor cell lines [21,22]. This 
supports the indirect cytotoxic mechanism of 
both extracts. 
 
The results also revealed that the ethanol 
extract showed significantly higher antitumor 
activity than the chloroform extract; this may 
be due to the presence of triterpenoids, 
alkaloids and tannins which might have 
enhanced the antitumor property of the 
flavonoids in the extract. On the other hand, 
triterpenoids and alkaloids in the chloroform 
extract appear not to have enhanced the 
antitumor property of phytosterols in the 
extract.  
 
Carcinogenesis or tumor development 
generates highly toxic and diffusible reactive 
oxygen species that cause extensive cell 
damage or adducts on the biomolecules, 
contributing to malignant transformation. 
Erythrocytes membranes are particularly 
susceptible to oxidative stress due to its high 
content of polyunsaturated fatty acids, which 
are more vulnerable to oxidative damages. 
The erythrocytes are particular susceptible to 
peroxide stress due to high content of iron, a 
potent catalyst for the production of reactive 
oxygen species and due to continuous 
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challenge with high oxygen tension [23]. 
Susceptibility of erythrocytes to peroxides 
was confirmed by the elevated WBC count, 
reduced hemoglobin and RBC count, as 
observed in the control group. The 
constituents of the extracts probably 
facilitated improvement in hematological 
parameters by scavenging reactive oxygen 
species and improving the antioxidant 
defense system, thus indicating that the 
extracts exerted haematopoietic protective 





The chloroform and ethanol extract of 
Cuscuta reflexa possess significant antitumor 
activity and increased the life span of tumor-
bearing mice. Further investigations are in 
progress in our laboratory to identity the 
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